These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1785 related articles for article (PubMed ID: 19659516)

  • 21. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R; Verma SK; Sahai S; Kumar S; Jain A
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia.
    Singla R; Al-Sharif N; Al-Sayegh MO; Osman MM; Shaikh MA
    Int J Tuberc Lung Dis; 2002 Jul; 6(7):585-91. PubMed ID: 12102297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baseline sputum time to detection predicts month two culture conversion and relapse in non-HIV-infected patients.
    Hesseling AC; Walzl G; Enarson DA; Carroll NM; Duncan K; Lukey PT; Lombard C; Donald PR; Lawrence KA; Gie RP; van Helden PD; Beyers N
    Int J Tuberc Lung Dis; 2010 May; 14(5):560-70. PubMed ID: 20392348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adding moxifloxacin is associated with a shorter time to culture conversion in pulmonary tuberculosis.
    Wang JY; Wang JT; Tsai TH; Hsu CL; Yu CJ; Hsueh PR; Lee LN; Yang PC
    Int J Tuberc Lung Dis; 2010 Jan; 14(1):65-71. PubMed ID: 20003697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the district tuberculosis programme.
    Datta M; Radhamani MP; Selvaraj R; Paramasivan CN; Gopalan BN; Sudeendra CR; Prabhakar R
    Tuber Lung Dis; 1993 Jun; 74(3):180-6. PubMed ID: 8369512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non conversion of sputum smears in new smear positive pulmonary tuberculosis patients in Yaoundé, Cameroon.
    Kuaban C; Bame R; Mouangue L; Djella S; Yomgni C
    East Afr Med J; 2009 May; 86(5):219-25. PubMed ID: 20084990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis.
    Su WJ; Feng JY; Chiu YC; Huang SF; Lee YC
    Eur Respir J; 2011 Feb; 37(2):376-83. PubMed ID: 20516049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors.
    Banu Rekha VV; Balasubramanian R; Swaminathan S; Ramachandran R; Rahman F; Sundaram V; Thyagarajan K; Selvakumar N; Adhilakshmi AR; Iliayas S; Narayanan PR
    Indian J Med Res; 2007 Nov; 126(5):452-8. PubMed ID: 18160750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection.
    Small PM; Schecter GF; Goodman PC; Sande MA; Chaisson RE; Hopewell PC
    N Engl J Med; 1991 Jan; 324(5):289-94. PubMed ID: 1898769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis.
    Kurbatova EV; Gammino VM; Bayona J; Becerra MC; Danilovitz M; Falzon D; Gelmanova I; Keshavjee S; Leimane V; Mitnick CD; Quelapio MI; Riekstina V; Taylor A; Viiklepp P; Zignol M; Cegielski JP
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1335-43. PubMed ID: 23107633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Follow-up observation on relapse of smear negative pulmonary tuberculosis after short-course chemotherapy].
    Xu WG; Gao Z; Fan BD
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):74-6. PubMed ID: 12783655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Randomized control study on domestic fixed-dose combinations in the initial treatment of smears positive tuberculosis].
    Xu WG; Lu W; He HJ; Gu XR
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Oct; 27(10):690-3. PubMed ID: 16201049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis.
    Botha FJ; Sirgel FA; Parkin DP; van de Wal BW; Donald PR; Mitchison DA
    S Afr Med J; 1996 Feb; 86(2):155-8. PubMed ID: 8619142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan - including a follow-up study.
    Kobashi Y; Matsushima T
    Respiration; 2007; 74(4):394-400. PubMed ID: 16954651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure.
    Ambreen A; Jamil M; Rahman MAU; Mustafa T
    BMC Infect Dis; 2019 Oct; 19(1):923. PubMed ID: 31666021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Epidemiological study on factors affecting the hospitalization period of patients with active tuberculosis].
    Fujino T; Fusegawa H; Nishiumi M; Okubo Y; Kakizaki T; Maejima K; Sugimori H
    Kekkaku; 2008 Aug; 83(8):567-72. PubMed ID: 18800648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of two treatment regimens for drug-resistant tuberculosis in tuberculosis control project areas: a comparative study].
    Li L; Zheng SH; Chu NH; Xie YG; Yang YZ; Li Q; Wang XM; Yan XL; Tan WG; Miao ZP; Duanmu HJ
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3387-91. PubMed ID: 19159566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The results of retreatment of pulmonary tuberculosis using a short 6-month protocol 1985-1991 in the pneumo-phthisiology department of the Point G hospital in Bamako].
    Kayantao D; Keïta B; Sangaré S
    Bull Soc Pathol Exot; 1997; 90(2):124-7. PubMed ID: 9289251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial.
    Cevik M; Thompson LC; Upton C; Rolla VC; Malahleha M; Mmbaga B; Ngubane N; Abu Bakar Z; Rassool M; Variava E; Dawson R; Staples S; Lalloo U; Louw C; Conradie F; Eristavi M; Samoilova A; Skornyakov SN; Ntinginya NE; Haraka F; Praygod G; Mayanja-Kizza H; Caoili J; Balanag V; Dalcolmo MP; McHugh T; Hunt R; Solanki P; Bateson A; Crook AM; Fabiane S; Timm J; Sun E; Spigelman M; Sloan DJ; Gillespie SH;
    Lancet Infect Dis; 2024 Sep; 24(9):1003-1014. PubMed ID: 38768617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 90.